I-Bankers Securities, Inc. 535 5th Avenue, 4th fl. New York, NY 10017 USANorthView Acquisition Corp • July 21st, 2023 • Surgical & medical instruments & apparatus • New York
This is to confirm our agreement whereby NorthView Acquisition Corp., a Delaware corporation (“Company”), has requested I-Bankers Securities, Inc. and Dawson James Securities, Inc. (the “Advisors”) to assist it in connection with the Company merging with, acquiring shares of, engaging in a share exchange, share reconstruction, recapitalization and amalgamation, purchasing all or substantially all of the assets of, entering into contractual arrangements, or engaging in any other similar business combination (in each case, a “Business Combination”) with one or more businesses or entities (each a “Target”) as described in the Company’s Registration Statement on Form S-1 (File No. 333-257156) filed with the Securities and Exchange Commission (“Registration Statement”) in connection with its initial public offering (“IPO”).
I-Bankers Securities, Inc. 535 5th Avenue, 4th fl. New York, NY 10017 USANorthView Acquisition Corp • July 21st, 2023 • Surgical & medical instruments & apparatus
Reference is made to (i) that certain Engagement Letter, dated as of October 4, 2021, by and between I-Bankers Securities, Inc. (“I-Bankers”), Dawson James Securities, Inc. (“Dawson James”) and NorthView Acquisition Corp. (“NorthView”) (the “Engagement Letter”) and (ii) that certain letter agreement, dated as of December 20, 2021, by and between I-Bankers, Dawson James, and NorthView (the “Business Combination Marketing Agreement”). This letter agreement serves to memorialize certain amendments to the Engagement Letter and the Business Combination Marketing Agreement (this “Omnibus Amendment”). In consideration of the mutual promises and agreements made herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:
